PlainRecalls
FDA Drug Low Class III Ongoing

Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540. Manufactured by: Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India, NDC 33342-398-44.

Reported: June 18, 2025 Initiated: May 29, 2025 #D-0470-2025

Product Description

Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540. Manufactured by: Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India, NDC 33342-398-44.

Reason for Recall

Presence of a foreign substance: black hair found embedded in tablet.

Details

Units Affected
1,344- 1000 count bottles
Distribution
Nationwide in the USA
Location
Mumbai

Frequently Asked Questions

What product was recalled?
Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540. Manufactured by: Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India, NDC 33342-398-44.. Recalled by Macleods Pharmaceuticals Ltd. Units affected: 1,344- 1000 count bottles.
Why was this product recalled?
Presence of a foreign substance: black hair found embedded in tablet.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 18, 2025. Severity: Low. Recall number: D-0470-2025.